Complex genetic control of host susceptibility to coxsackievirus B3-induced myocarditis

被引:32
作者
Aly, M.
Wiltshire, S.
Chahrour, G.
Osti, J-C Loredo
Vidal, S. M.
机构
[1] McGill Univ, Dept Human Genet, Montreal, PQ H3A 2B4, Canada
[2] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1N 6N5, Canada
[3] Mem Univ Newfoundland, Dept Math & Stat, St John, NF A1C 5S7, Canada
[4] McGill Univ, McGill Ctr Study Host Resistance, Montreal, PQ H3A 2B4, Canada
基金
加拿大健康研究院;
关键词
viral myocarditis; mouse model; complex trait; coxsackievirus; inflammation; infectious disease;
D O I
10.1038/sj.gene.6364374
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The pathogenesis of viral myocarditis is a multifactorial process involving host genetics, viral genetics and the environment in which they interact. We have used a model of infection with coxsackievirus B3 (CVB3) to characterize the contribution of host genetics to viral myocarditis in mice of different genetic backgrounds but with a common H2 haplotype: A/J and B10.A-H2(a). Here we have used Evans blue dye as a quantitative biomarker for susceptibility to CVB3-induced myocarditis in addition to histopathological semiquantitative measures. We have found evidence of linkage between susceptibility to viral myocarditis and three loci. A locus on chromosome 1 centered on D1Mit200 was linked to sarcolemmal disruption in males ( P = 0.00005), a second locus on chromosome 4 centered on D4Mit81 was also linked to sarcolemmal disruption in males ( P = 0.0022). A third locus on distal chromosome 3 centered on D3Mit19 was linked to myocardial infiltration, with a logarithm of odds (LOD) score of 4.7 ( P = 0.0045), as well as sarcolemmal disruption in females ( P = 0.0015). These results provide strong evidence for the presence of loci contributing to the susceptibility of mice to viral myocarditis.
引用
收藏
页码:193 / 204
页数:12
相关论文
共 59 条
[1]  
[Anonymous], 1989, GEN LINEAR MODEL
[2]  
ARETZ HT, 1987, HUM PATHOL, V18, P619
[3]   Bone marrow chimeras reveal non-H-2 hematopoietic control of susceptibility to Theiler's virus persistent infection [J].
Aubagnac, S ;
Brahic, M ;
Bureau, JF .
JOURNAL OF VIROLOGY, 2002, 76 (11) :5807-5812
[4]   Dissecting mechanisms of innate and acquired immunity in myocarditis [J].
Ayach, B ;
Fuse, K ;
Martino, T ;
Liu, P .
CURRENT OPINION IN CARDIOLOGY, 2003, 18 (03) :175-181
[5]   Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy [J].
Badorff, C ;
Lee, GH ;
Lamphear, BJ ;
Martone, ME ;
Campbell, KP ;
Rhoads, RE ;
Knowlton, KU .
NATURE MEDICINE, 1999, 5 (03) :320-326
[6]   Diagnosis of myocarditis - Death of Dallas criteria [J].
Baughman, KL .
CIRCULATION, 2006, 113 (04) :593-595
[7]   Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5 [J].
Bergelson, JM ;
Cunningham, JA ;
Droguett, G ;
KurtJones, EA ;
Krithivas, A ;
Hong, JS ;
Horwitz, MS ;
Crowell, RL ;
Finberg, RW .
SCIENCE, 1997, 275 (5304) :1320-1323
[8]   R/qtl: QTL mapping in experimental crosses [J].
Broman, KW ;
Wu, H ;
Sen, S ;
Churchill, GA .
BIOINFORMATICS, 2003, 19 (07) :889-890
[9]   Sarcomeric protein mutations in dilated cardiomyopathy [J].
Chang, AN ;
Potter, JD .
HEART FAILURE REVIEWS, 2005, 10 (03) :225-235
[10]  
CHOW LH, 1991, LAB INVEST, V64, P55